Combined therapeutical treatment of hyperproliferative diseases

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01) A61K 31/70 (2006.01) A61K 33/24 (2006.01) A61K 38/19 (2006.01)

Patent

CA 2209771

A medicinal combination of one or more nucleic acids that at least partially inhibit oncogenic cell signalling pathways, and a therapeutic anticancer agent, for use simultaneous, separate or over a period of time to treat hyperproliferative diseases.

La présente invention concerne une association médicamenteuse d'un ou plusieurs acides nucléiques inhibant au moins partiellement les voies de signalisation cellulaires oncogéniques, et d'un agent thérapeutique anticancéreux, pour une utilisation simultanée, séparée ou étalée dans le temps pour le traitement des pathologies hyperprolifératives.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combined therapeutical treatment of hyperproliferative diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combined therapeutical treatment of hyperproliferative diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined therapeutical treatment of hyperproliferative diseases will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1880210

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.